Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Dong‐Ying Xie"'
Autor:
Li-Li Wu, Xiao-Yan Li, Kai Deng, Bing-Liang Lin, Hong Deng, Dong-Ying Xie, Geng-Lin Zhang, Qi-Yi Zhao, Zhi-Shuo Mo, Yue-Hua Huang, Zhi-Liang Gao
Publikováno v:
Liver Research, Vol 7, Iss 2, Pp 136-144 (2023)
Background and aims: The primary goal of chronic hepatitis B (CHB) treatment is to reduce hepatitis B surface antigen (HBsAg). T helper 17 (Th17) and regulatory T (Treg) cells are essential for the development of CHB. However, how Th17 and Treg cells
Externí odkaz:
https://doaj.org/article/8d959db95e01445fb794174860636754
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2018 (2018)
T follicular helper cells (Tfh cells) affect essential immune pathogenesis in chronic hepatitis B virus (HBV) infection. The CCR7loPD-1hi Tfh subset has a partial Tfh effector phenotype and is associated with active Tfh differentiation, whereas the C
Externí odkaz:
https://doaj.org/article/6cdf8a91a6314efa9cac71ae02fba6ed
Autor:
Wen-xiong Xu, Qian Zhang, Xiang Zhu, Chao-shuang Lin, You-ming Chen, Hong Deng, Yong-yu Mei, Zhi-xin Zhao, Dong-ying Xie, Zhi-liang Gao, Chan Xie, Liang Peng
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2018 (2018)
Background and Aims. We aimed to ascertain the feasibility and safety of NA cessation, the status of patients after cessation, and the predictive factors for relapse and subsequent retreatment. Methods. A total of 92 patients were enrolled in this pr
Externí odkaz:
https://doaj.org/article/9a97197e65d34900927f1b81f215ff10
Autor:
Jun-feng Chen, Miao Huang, Shao-quan Zhang, Hui-juan Cao, Wei-zhen Weng, Jing Xiong, Dong-ying Xie, Zhi-liang Gao, Bing-liang Lin
Publikováno v:
Cogent Medicine, Vol 4, Iss 1 (2017)
Objective: Ascites is one of the most frequent complications of cirrhosis. Our study is to investigate the efficacy and safety of the intermittent drainage of ascites for HBV-related cirrhosis patients with tense ascites. Material and methods: A tota
Externí odkaz:
https://doaj.org/article/079af211e8144e07af4206244fe3de9f
Autor:
Chan Xie, Li-bing Song, Jue-heng Wu, Jun Li, Jing-ping Yun, Jia-ming Lai, Dong-ying Xie, Bing-liang Lin, Yun-fei Yuan, Mengfeng Li, Zhi-liang Gao
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e40607 (2012)
ObjectiveThe goal of the present study was to investigate the potential correlation between the expression level of upregulator of cell proliferation (URGCP/URG4) and the prognosis of hepatocellular carcinoma (HCC), and to examine the biological func
Externí odkaz:
https://doaj.org/article/10fcb5c6c7ca4719bda1fb2a6b5ae210
Autor:
Pei-pei Wang, Dong-ying Xie, Xu-Jing Liang, Liang Peng, Geng-lin Zhang, Yi-nong Ye, Chan Xie, Zhi-liang Gao
Publikováno v:
PLoS ONE, Vol 7, Iss 8, p e43408 (2012)
AIMS: Bone marrow-derived mesenchymal stem cells (BMSCs) can reduce liver fibrosis. Apart from the paracrine mechanism by which the antifibrotic effects of BMSCs inhibit activated hepatic stellate cells (HSCs), the effects of direct interplay and jux
Externí odkaz:
https://doaj.org/article/80d35b7435354d518f3b835ecafdd873
Autor:
Yu-Bao Zheng, Xiao-Hong Zhang, Zhan-Lian Huang, Chao-Shuang Lin, Jing Lai, Yu-Rong Gu, Bin-Liang Lin, Dong-Ying Xie, Shi-Bin Xie, Liang Peng, Zhi-Liang Gao
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e41392 (2012)
Uncontrolled hepatic immunoactivation is regarded as the primary pathological mechanism of fulminant hepatic failure (FHF). The major acute-phase mediators associated with FHF, including IL-1β, IL-6, and TNF-α, impair the regeneration of liver cell
Externí odkaz:
https://doaj.org/article/55dd85bc51954720b1fdaffdea8f988e
Autor:
Jun‐Hao Chu, Yan Huang, Dong‐Ying Xie, Hong Deng, Jia Wei, Yu‐Juan Guan, Guo‐Jun Li, Yi‐Lan Zeng, Jia‐Hong Yang, Xin‐Yue Chen, Jia Shang, Jia‐Bin Li, Na Gao, Zhi‐Liang Gao
Publikováno v:
Journal of Viral Hepatitis. 29:765-776
Combination therapy with pegylated interferon (PEG-IFN) and nucleos(t)ide analogues (NAs) can enhance hepatitis B surface antigen (HBsAg) clearance. However, the specific treatment strategy and the patients who would benefit the most are unclear. The
Autor:
Xiu-Qing Pang, Xing Li, Wei-Hang Zhu, Run-Kai Huang, Zhi-shuo Mo, Ze-Xuan Huang, Yuan Zhang, Dong-Ying Xie, Zhi-Liang Gao
Publikováno v:
Antiviral Research. 213:105592
Publikováno v:
Liver Research, Vol 5, Iss 2, Pp 97-101 (2021)
Interferon (IFN) is a multifaceted immunomodulator that is effective against many diseases, including chronic hepatitis B and chronic hepatitis C infection. IFN defends against viral infection, but may also cause various side effects, such as ulcerat